United Kingdom
Convenia logo

Periodontal Infections

As adjunctive treatment to mechanical or surgical therapy of severe infections of the gingival and periodontal tissues*

 

Convenia demonstrates equivalent efficacy to clindamycin in reducing bleeding on probing1

Bleeding on Probing
Click image to enlarge

Convenia offers equivalent efficacy to clindamycin in reducing pocket depth1

reduction of gingival pocket depth
Click image to enlarge

Convenia significantly reduced the growth of Porphyromonas gulae, one of the most frequently isolated black pigmented anaerobic bacteria in canine periodontitis**1, 2

Effects on bacterial growth
Click image to enlarge

 

REFERENCES
1Pfizer Study number 5163C-85-07-354
2Hardham J et al. 2005. Veterinary Microbiology; 106, 119-128
*Associated with Porphyromonas spp and Prevotella spp
**Versus clindamycin
†Treatment differences were statistically significant p <0.0001

It is prudent to reserve 3rd-generation cephalosporins for clinical conditions responding poorly or expected to respond poorly to other classes of antimicrobials or 1st-generation cephalosporins.  Convenia use should be based on susceptibility testing.

Skin and soft tissue infections

Periodontal infections

Urinary Tract infections